US/Silver Spring:
Allergan plc, an Irvine, California establishment, recalls certain batch/lots of Taytulla Softgel Contraceptive (Birth Control) Capsules due to suspected presence of out-of-sequence Capsules and consequential risk of contraceptive failure and unintended pregnancy, all serious health and safety hazards.
Direct link: https://www.fda.gov/Safety/Recalls/ucm609044.htm
Additional information:
The US Food and Drug Administration (“FDA”) reports the following Contraceptive Capsules are subject to this recall:
Filed under: Assistive, health or safety devices, Drugs, Labeling or regulatory issues, oral contraceptives, Taytulla, US FDA | Tagged: Allergan, drug, FDA, operational failure hazard, Recalls Direct RIN: 10239-2018, suspected Contraceptive failure hazard, Taytulla, Taytulla Softgel Contraceptive | Leave a comment »